ES2106784T3 - Factor de transferencia y metodos de uso. - Google Patents

Factor de transferencia y metodos de uso.

Info

Publication number
ES2106784T3
ES2106784T3 ES91913547T ES91913547T ES2106784T3 ES 2106784 T3 ES2106784 T3 ES 2106784T3 ES 91913547 T ES91913547 T ES 91913547T ES 91913547 T ES91913547 T ES 91913547T ES 2106784 T3 ES2106784 T3 ES 2106784T3
Authority
ES
Spain
Prior art keywords
transfer factor
methods
absorbence
per unit
substantially pure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91913547T
Other languages
English (en)
Inventor
Charles H Kirkpatrick
Stephen J Rozzo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Jewish Health
Original Assignee
National Jewish Center for Immunology and Respiratory Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Jewish Center for Immunology and Respiratory Medicine filed Critical National Jewish Center for Immunology and Respiratory Medicine
Application granted granted Critical
Publication of ES2106784T3 publication Critical patent/ES2106784T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA INVENCION SE REFIERE A UN FACTOR DE TRANSFERENCIA SUBSTANCIALMENTE PURO CON UNA ACTIVIDAD ESPECIFICA DE AL MENOS 5000 UNIDADES POR UNIDAD DE ABSORBENCIA A 214 NM. LAS PRESENTE INVENCION TAMBIEN SE REFIERE A UN PROCESO PARA PREPARAR EL FACTOR DE TRANSFERENCIA A PARTIR DE LISATOS CELULARES. LA INVENCION INCLUYE EL USO DEL FACTOR DE TRANSFERENCIA SUBSTANCIALMENTE PURO CON UNA ACTIVIDAD ESPECIFICA DE AL MENOS 5000 UNIDADES POR UNIDAD DE ABSORBENCIA A 214 NM PARA TRATAR ENFERMEDADES INFECCIOSAS.
ES91913547T 1990-07-02 1991-07-02 Factor de transferencia y metodos de uso. Expired - Lifetime ES2106784T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54750090A 1990-07-02 1990-07-02
US71857191A 1991-06-26 1991-06-26

Publications (1)

Publication Number Publication Date
ES2106784T3 true ES2106784T3 (es) 1997-11-16

Family

ID=27068558

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91913547T Expired - Lifetime ES2106784T3 (es) 1990-07-02 1991-07-02 Factor de transferencia y metodos de uso.

Country Status (12)

Country Link
US (2) US5470835A (es)
EP (1) EP0537280B1 (es)
JP (1) JPH05508847A (es)
KR (1) KR0184598B1 (es)
AT (1) ATE158184T1 (es)
AU (1) AU657915B2 (es)
CA (1) CA2086610A1 (es)
DE (1) DE69127694T2 (es)
DK (1) DK0537280T3 (es)
ES (1) ES2106784T3 (es)
GR (1) GR3025282T3 (es)
WO (1) WO1992000093A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883224A (en) * 1996-04-19 1999-03-16 Cytokine Sciences, Inc. Characterization of transfer factors and methods of use
US5858378A (en) * 1996-05-02 1999-01-12 Galagen, Inc. Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen
US6136794A (en) * 1998-02-02 2000-10-24 Merck & Co., Inc. Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist
CA2357685A1 (en) * 2000-09-18 2002-03-18 Chisolm Biological Laboratory, Llc Transfer factor composition and process for producing same
US6468534B1 (en) * 2000-09-21 2002-10-22 4Life Research, Lc Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use
US20060073197A1 (en) * 2004-05-20 2006-04-06 Ramaekers Joseph C Encapsulated transfer factor compositions and methods of use
US6506413B1 (en) * 2001-04-30 2003-01-14 Joseph C. Ramaekers Compositions for treating animal diseases and syndromes
US20070128253A1 (en) * 2005-04-13 2007-06-07 Ramaekers Joseph C Encapsulated transfer factor compositions and methods of use
MXPA02002171A (es) * 2002-02-28 2002-12-09 Antonio Calzada Nova Luis Extracto de leucocitos dializado en la elaboracion de un farmaco para el tratamiento de enfermedades infecciosas en animales.
WO2004017916A2 (en) 2002-08-22 2004-03-04 4Life Research, Lc Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition
AU2003295395A1 (en) * 2002-11-04 2004-06-07 4Life Research, Lc Compositions, systems, and methods for focusing a cell-mediated immune response
US6866868B1 (en) * 2003-09-15 2005-03-15 4Life Research, Lc Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
CN100394178C (zh) * 2006-01-23 2008-06-11 武汉海特生物制药股份有限公司 一种特异性转移因子主要有效成分含量的检测方法
CZ299296B6 (cs) * 2006-06-13 2008-06-11 Sevapharma A.S. Lécivo transfer faktor - zpusob výroby a použití
US20090053197A1 (en) * 2006-06-14 2009-02-26 Ramaekers Joseph C Transfer Factor Compositions and Methods
US9125874B2 (en) 2007-11-30 2015-09-08 The Ramaekers Family Trust Administration of transfer factor for improving reproductive health
US20090074751A1 (en) * 2007-09-18 2009-03-19 Ramaekers Nutrition, Inc. Growth factor fraction compositions and methods
WO2009070788A1 (en) 2007-11-30 2009-06-04 The Ramaekers Family Trust Compositions and methods for enhancing fertility
ES2742734T3 (es) 2010-11-23 2020-02-17 Pantheryx Inc Composiciones y procedimientos para el tratamiento en aplicaciones clínicas de espectro general, no diferenciadas o mixtas
MX338863B (es) * 2011-12-16 2016-05-01 Inst Politecnico Nacional Metodo de obtencion de extracto dializable de leucocitos.
WO2020176637A1 (en) 2019-02-26 2020-09-03 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991182A (en) * 1971-10-19 1976-11-09 The Regents Of The University Of California Transfer factor
US4001080A (en) * 1972-10-20 1977-01-04 Piktor Limited Production of immunological materials
US3991132A (en) * 1973-09-06 1976-11-09 Ford Motor Company Powder paint with epoxy and amide copolymer with anhydrides and hydroxy acids
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
IN150740B (es) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4468372A (en) * 1980-03-20 1984-08-28 Jakob Harich Hygienic air purifying device
NO156516C (no) * 1980-05-14 1987-10-07 A Arthur Gottlieb Fremgangsmaate for fremstilling av modulatorer for immunsystemet.
US4435384A (en) * 1982-04-30 1984-03-06 Viragen, Inc. Transfer factor composition and skin treatment
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system
AU1696283A (en) * 1982-07-20 1984-01-26 Bio-Com Inc. Transfer factor for viral treatment
US4816563A (en) * 1983-11-25 1989-03-28 Amtron, Inc. Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof
US4616079A (en) * 1984-08-24 1986-10-07 Imreg, Inc. Immunoamplifiers and processes for the extraction thereof
AU8107191A (en) * 1990-07-02 1992-01-23 National Jewish Center For Immunology And Respiratory Medicine Process for obtaining pure peptide transfer factor, transfer factor thus obtained and uses thereof

Also Published As

Publication number Publication date
AU8195791A (en) 1992-01-23
AU657915B2 (en) 1995-03-30
KR0184598B1 (ko) 1999-05-01
ATE158184T1 (de) 1997-10-15
GR3025282T3 (en) 1998-02-27
US5840700A (en) 1998-11-24
DK0537280T3 (da) 1997-10-13
EP0537280B1 (en) 1997-09-17
DE69127694T2 (de) 1998-04-02
JPH05508847A (ja) 1993-12-09
DE69127694D1 (de) 1997-10-23
WO1992000093A1 (en) 1992-01-09
CA2086610A1 (en) 1992-01-03
EP0537280A1 (en) 1993-04-21
EP0537280A4 (en) 1993-09-08
US5470835A (en) 1995-11-28

Similar Documents

Publication Publication Date Title
DK0537280T3 (da) Fremstilling og anvendelse af transfer-faktor
ATE192653T1 (de) Anwendungen von acemannan
AU644095B2 (en) Antiviral compounds
ES2058892T3 (es) Uso de omeprazol como agente antimicrobiano.
PT86831A (pt) Process for preparing sustained release matrix formulations
ES2052574T3 (es) Antibioticos glicopeptidos.
DE3575927D1 (de) Purinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
IL104780A0 (en) Sulfonic acid derivatives in the treatment of viral diseases
ES2075378T3 (es) Procedimiento para la preparacion del factor viii humano y de analogos del factor viii.
GR3002377T3 (en) Ifosfamide-mesna-lyophilized composition and process to prepare it
GB9014724D0 (en) Process for the preparation of alpha,beta-olefinically unsaturated compounds
PT97621A (pt) Processo para a preparacao de vacinas contra o papilomavirus humano 18 (hpv 18)
USD257358S (en) Body and illuminator of a tissue culture microscope
ES2067921T3 (es) Una biomasa y un procedimiento para la produccion de virus/antigeno de virus.
ES548242A0 (es) Procedimiento para la produccion de glicopeptidos y -o oligosacaridos
DK23490A (da) Implanteret antibiotisk tilberedning med reguleret frigivelse
NO914986D0 (no) Fremgangsmaate for fremstilling av anti-herpescastanosperminestere
FR2564106B1 (fr) Vecteurs d'expression du facteur ix, cellules transformees par ces vecteurs et procede de preparation du facteur ix.
BR9610932A (pt) Processo para armazenar microorganismos, composição de microorganismos e utilização da mesma
IE781308L (en) Benzylpyrimidines
GR3008746T3 (es)
AU7016491A (en) Use of benzylphosphonic acid derivatives for the treatment of diseases caused by viruses
ES2061722T3 (es) Derivados de fenantridina, procedimiento para su obtencion y agentes para la realizacion del procedimiento.
USD257357S (en) Body of a tissue culture microscope

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 537280

Country of ref document: ES